Mesa Labs appoints Mark Capone to board of directors

Mesa Laboratories announced the appointment of Mark Capone to its Board of Directors, effective January 5, 2024. Following Mr. Capone’s election, the Mesa Board will be comprised of 7 directors, the majority of whom are independent. The Board is committed to ongoing director refreshment and continues to consider new, qualified independent directors. Capone most recently served as CEO and President of Myriad Genetics for five years